Cargando…

HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation

Histone deacetylase 9 (HDAC9), a member of class II HDACs, regulates a wide variety of normal and abnormal physiological functions. We found that HDAC9 is over-expressed in prognostically poor glioblastoma patients. Knockdown HDAC9 decreased proliferation in vitro and tumor formation in vivo. HDAC9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Rui, Wu, Yanan, Wang, Mei, Sun, Zhongfeng, Zou, Jiahua, Zhang, Yundong, Cui, Hongjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480706/ https://www.ncbi.nlm.nih.gov/pubmed/25760078

Ejemplares similares

The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway
por: Yang, Rui, et al.
Publicado: (2016)

Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β
por: Wang, Mei, et al.
Publicado: (2015)

MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells
por: Dong, Zhen, et al.
Publicado: (2019)

RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway
por: Hou, Jianbing, et al.
Publicado: (2021)

Mechanical Properties of Glioblastoma: Perspectives for YAP/TAZ Signaling Pathway and Beyond
por: Pontes, Bruno, et al.
Publicado: (2023)

ZC3H15 promotes glioblastoma progression through regulating EGFR stability
por: Hou, Jianbing, et al.
Publicado: (2022)

High expression of TAZ indicates a poor prognosis in retinoblastoma
por: Zhang, Yiting, et al.
Publicado: (2015)

Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
por: Moon, Hyuk, et al.
Publicado: (2022)

TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis
por: Wang, Shuren, et al.
Publicado: (2016)

TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition
por: Xu, Longxia, et al.
Publicado: (2023)

Induction of store operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ
por: Liu, Zhijun, et al.
Publicado: (2018)

Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma
por: Yang, Jia, et al.
Publicado: (2023)

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
por: Escoll, Maribel, et al.
Publicado: (2020)

EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
por: Fang, Runping, et al.
Publicado: (2021)

HOXC10 promotes growth and migration of melanoma by regulating Slug to activate the YAP/TAZ signaling pathway
por: Miao, Yuanxin, et al.
Publicado: (2021)

TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
por: Yuan, Weiwei, et al.
Publicado: (2019)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment
por: Sidorov, Maxim, et al.
Publicado: (2023)

Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis
por: Chen, Mei, et al.
Publicado: (2017)

YAP/TAZ: Molecular pathway and disease therapy
por: Wei, Yuzi, et al.
Publicado: (2023)

S645C Point Mutation Suppresses Degradation of EGFR to Promote Progression of Glioblastoma
por: Huang, Wenda, et al.
Publicado: (2022)

TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway
por: Gu, Hongyu, et al.
Publicado: (2022)

E2F7−EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression
por: Yang, Rui, et al.
Publicado: (2020)

HDAC inhibitors and their potential applications to glioblastoma therapy
por: Adamopoulou, Eleni, et al.
Publicado: (2013)

JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis
por: Ding, Kun, et al.
Publicado: (2023)

TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway
por: Hou, Jianbing, et al.
Publicado: (2019)

Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma
por: Castellan, Martina, et al.
Publicado: (2021)

Deficiency of G9a Inhibits Cell Proliferation and Activates Autophagy via Transcriptionally Regulating c-Myc Expression in Glioblastoma
por: Ke, Xiao Xue, et al.
Publicado: (2020)

HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability
por: Dai, Hong-Ying, et al.
Publicado: (2022)

Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators as a Therapy for Glioblastoma
por: Nadeem Abbas, Muhammad, et al.
Publicado: (2019)

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
por: Xu, Wei, et al.
Publicado: (2015)

Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
por: Shen, Jia, et al.
Publicado: (2018)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
por: Kovar, Heinrich, et al.
Publicado: (2020)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway
por: Yang, Rui, et al.
Publicado: (2021)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
por: Everix, Liesbeth, et al.
Publicado: (2023)

Epidermal growth factor receptor (EGFR) and EGFRvIII in glioblastoma (GBM): signaling pathways and targeted therapies
por: An, Zhenyi, et al.
Publicado: (2018)

Yap/Taz transcriptional activity in endothelial cells promotes intramembranous ossification via the BMP pathway
por: Uemura, Mami, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5icl5jmf32s7dcj345cc63sqoe